Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results Director comp.
|
Oncology Institute, Inc. (DFPH)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
12/30/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
11/22/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
11/22/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
11/22/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
11/22/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
11/22/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
03/29/2022 |
4/A
| Miller Matthew P (COO) has filed a Form 4 on Oncology Institute, Inc.
Txns:
| Granted 32,417 options to buy
@ $7.09, valued at
$229.8k
Granted 109,844 options to buy
@ $7.09, valued at
$778.8k
|
|
03/29/2022 |
4/A
| Podnos Yale (Chief Medical Officer) has filed a Form 4 on Oncology Institute, Inc.
Txns:
| Granted 10,984 options to buy
@ $7.09, valued at
$77.9k
Granted 64,567 options to buy
@ $7.09, valued at
$457.8k
|
|
03/29/2022 |
4/A
| Virnich Daniel (President) has filed a Form 4 on Oncology Institute, Inc.
Txns:
| Granted 213,259 options to buy
@ $7.09, valued at
$1.5M
|
|
03/29/2022 |
4/A
| Dalgleish Scott (CFO) has filed a Form 4 on Oncology Institute, Inc.
Txns:
| Granted 162,891 options to buy
@ $7.09, valued at
$1.2M
|
|
03/29/2022 |
4/A
| Hively Brad (CEO) has filed a Form 4 on Oncology Institute, Inc.
Txns:
| Granted 550,563 options to buy
@ $7.09, valued at
$3.9M
|
|
11/22/2021 |
4/A
| SARIN RAVI YANG (Director) has filed a Form 4 on Oncology Institute, Inc.
Txns:
| Granted 4,109,771 shares
@ $0 Granted 348,998 options to buy
@ $0 Granted 523,497 options to buy
@ $0 |
|
11/18/2021 |
4/A
| Hively Brad (CEO) has filed a Form 4 on Oncology Institute, Inc.
Txns:
| Granted 141,380 shares
@ $0 Granted 212,070 shares
@ $0 |
|
11/18/2021 |
4/A
| Kaushal Mohit (Director) has filed a Form 4 on Oncology Institute, Inc.
Txns:
| Exercised 30,000 options to buy
@ $0 |
|
11/18/2021 |
4/A
| BARASCH RICHARD A (Director) has filed a Form 4 on Oncology Institute, Inc.
Txns:
| Disposed/sold 14,887 shares
@ $0 Exercised 100,000 options to buy
@ $0 |
|
|
|